Abstract
AIMS—To evaluate the data for patients with basal cell carcinoma (BCC) in the eyelid region, to demonstrate histologically controlled tumour excision, and to prove the efficacy of the treatment on the basis of long term observations. METHODS—Retrospective analysis of 382 microscopically controlled BCC excisions in the eyelid apparatus (350 patients) in a follow up study over 5.7 (SD 1.1) years. Tumour location, tumour size, and histological results were recorded. The same procedure was followed for recurrences. Follow up examinations were carried out 1, 3, 6, and 12 months after the operation, and then annually for a further 4 years or longer. RESULTS—A recurrence rate of 5.36% was observed after the primary operation. 60.3% of first recurrences occurred in the medial canthus, 41.2% showed in depth extension, and sclerosing types were overly represented at 35.3%. After the second operation the recurrence rate increased to 14.7% and reached 50% after a third and fourth operation. CONCLUSIONS—The greatest risk of recurrence exists for BCCs of the medial canthus with in depth extension, and for sclerosing types. The recurrence rate increases after every operation. For high risk cases, consideration should be given to adjuvant treatment such as radiotherapy. Keywords: basal cell carcinoma; eyelid
Full Text
The Full Text of this article is available as a PDF (125.7 KB).
Figure 1 .
(A) Location, (B) size, and (C) histological results of basal cell carcinoma in the eyelid region.
Figure 2 .
(A) Location, (B) size, and (C) histological results of basal cell carcinoma recurrences in the eyelid region.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Einaugler R. B., Henkind P. Basal cell epithelioma of the eyelid: apparent incomplete removal. Am J Ophthalmol. 1969 Mar;67(3):413–417. doi: 10.1016/0002-9394(69)92057-1. [DOI] [PubMed] [Google Scholar]
- Fitzpatrick P. J., Jamieson D. M., Thompson G. A., Allt W. E. Tumors of the eyelids and their treatment by radiotherapy. Radiology. 1972 Sep;104(3):661–665. doi: 10.1148/104.3.661. [DOI] [PubMed] [Google Scholar]
- Lober C. W., Fenske N. A. Basal cell, squamous cell, and sebaceous gland carcinomas of the periorbital region. J Am Acad Dermatol. 1991 Oct;25(4):685–690. doi: 10.1016/0190-9622(91)70254-y. [DOI] [PubMed] [Google Scholar]
- Margo C. E., Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol. 1993 Sep-Oct;38(2):169–192. doi: 10.1016/0039-6257(93)90100-l. [DOI] [PubMed] [Google Scholar]
- Mehta H. Surgical management of carcinoma of eyelids and periorbital skin. Br J Ophthalmol. 1979 Aug;63(8):578–585. doi: 10.1136/bjo.63.8.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rakofsky S. I. The adequacy of the surgical excision of basal cell carcinoma. Ann Ophthalmol. 1973 May;5(5):596–600. [PubMed] [Google Scholar]
- Steinkogler F. J. Treatment of upper eyelid entropion. Lid split surgery and fibrin sealing of free skin transplants. Ophthal Plast Reconstr Surg. 1986;2(4):183–187. [PubMed] [Google Scholar]
- Swanson N. A. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol. 1983 Sep;119(9):761–773. doi: 10.1001/archderm.119.9.761. [DOI] [PubMed] [Google Scholar]
- Tijl J. W., Koornneff L. The optimal follow-up time for a basal cell carcinoma of the eyelid. Doc Ophthalmol. 1990 Oct;75(3-4):275–279. doi: 10.1007/BF00164841. [DOI] [PubMed] [Google Scholar]
- Vitaliano P. P., Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol. 1980 Apr;116(4):454–456. [PubMed] [Google Scholar]
- Wilson B. D., Mang T. S., Stoll H., Jones C., Cooper M., Dougherty T. J. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol. 1992 Dec;128(12):1597–1601. [PubMed] [Google Scholar]